Company news

Purple Biotech Ltd. news in 2026

Purple Biotech Ltd.'s news releases, calls and decks from 2026, newest first.

View company

Purple Biotech Announces New Data from CAPTN-3 Platform Tri-specific IM1240

April 27, 2026

Purple Biotech Establishes Scientific Advisory Board to Support Development of CAPTN-3 Tri-Specific Antibody Platform

April 23, 2026

Purple Biotech Announces AI Collaboration with Converge Bio to Accelerate Development of its Next-Generation Tri-Specific Antibody Platform

March 25, 2026

Purple Biotech Regains Compliance with Nasdaq

March 17, 2026

Purple Biotech Announces CEO Transition

March 13, 2026

Purple Biotech Announces Plan to Implement ADS Ratio Change

February 25, 2026

Purple Biotech Achieves Toxicology Milestone Demonstrating an Expanded Therapeutic Window for CAPTN-3 Platform Tri-specific Antibody, IM1240

January 7, 2026

Decks in 2026